Virology Testing Market Report 2026

Virology Testing Market Report 2026
Global Outlook – By Type (Instruments, Assay Kits And Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay Based Method, Mass Spectroscopy Based Method, Other Techniques), By Application (Skin And Soft Tissue Infections, Respiratory Tract Infections, Gastrointestinal Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), By End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) - Market Size, Trends, And Global Forecast 2026-2035
Virology Testing Market Overview
• Virology Testing market size has reached to $5.8 billion in 2025 • Expected to grow to $9.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Surging Viral Infections Drive Growth In The Virology Testing Market To Enhance Need For Accurate Diagnosis • Market Trend: Advancements In Technology Drive Virology Testing Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Virology Testing Market?
Virology testing refers to diagnosing viral infections by detecting the presence of viruses or specific viral components in biological samples, such as blood, saliva, or tissue. These tests are used in identifying, monitoring, and controlling viral diseases. The main types of virology testing are instruments, assay kits, and consumables. Instruments in the context of virology testing refer to specialized equipment and devices used for conducting various diagnostic tests and procedures. Molecular diagnostics method, immunoassay-based method, mass spectroscopy-based method, and other techniques are used for various applications including skin and soft tissue infections, respiratory tract infections, gastrointestinal tract infections, urinary tract infections, eye infections, sexually transmitted diseases, and perinatal infections by hospitals, clinics, laboratories, diagnostic centers, blood banks, and pharmacies.
What Is The Virology Testing Market Size and Share 2026?
The virology testing market size has grown rapidly in recent years. It will grow from $5.8 billion in 2025 to $6.41 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing prevalence of viral infections, expansion of hospital diagnostic infrastructure, rising adoption of PCR-based testing, growth of centralized diagnostic laboratories, improved availability of assay kits.What Is The Virology Testing Market Growth Forecast?
The virology testing market size is expected to see rapid growth in the next few years. It will grow to $9.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for point-of-care virology testing, rising investments in molecular diagnostics, expansion of personalized medicine approaches, growing use of multiplex testing platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of molecular diagnostic testing, rising use of high-throughput pcr platforms, growing integration of automated assay systems, expansion of syndromic testing panels, enhanced focus on rapid and accurate results.Global Virology Testing Market Segmentation
1) By Type: Instruments, Assay Kits And Consumables 2) By Diagnostic Technique: Molecular Diagnostics Method, Immunoassay Based Method, Mass Spectroscopy Based Method, Other Techniques 3) By Application: Skin And Soft Tissue Infections, Respiratory Tract Infections, Gastrointestinal Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections 4) By End User: Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies Subsegments: 1) By Instruments: PCR Machines, Sequencers, Microplate Readers, Immunoassay Analyzers 2) By Assay Kits And Consumables: PCR Assay Kits, ELISA Kits, Rapid Test Kits, Viral Culture Kits, Sample Collection Kits, Pipette Tips, Culture MediaWhat Is The Driver Of The Virology Testing Market?
The rising incidence of viral infections is expected to propel the growth of the virology testing market going forward. Viral infections are infectious diseases caused by viruses, microscopic infectious agents composed of genetic material (DNA or RNA) surrounded by a protein coat. Virology testing is essential for accurate diagnosis, surveillance, research, and public health preparedness. It enables the identification of viral pathogens, guides treatment strategies, tracks the spread of infections, and supports the development of new interventions. The increasing demand for virology testing stems from the need to manage viral infections and mitigate their impact effectively. For instance, in September 2024, according to GOV.UK, a UK-based government services and information provider, between week 40 of 2023 and week 14 of 2024 in England, where virological testing results were available, 708 incidents (53.3%) were confirmed as SARS-CoV-2, followed by 472 incidents of influenza (35.5%), 68 incidents of RSV (5.1%), and 80 incidents (6.0%) involving other viruses. Therefore, the rising incidence of viral infections is driving the growth of the virology testing industry.Key Players In The Global Virology Testing Market
Major companies operating in the virology testing market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc., Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Vircell SLGlobal Virology Testing Market Trends and Insights
Major companies operating in the virology testing market are focusing on advanced solutions such as, agar gel precipitation test solutions, to fulfill the increasing demand for accurate diagnostic tools. Advanced agar gel precipitation test solutions are specialized mixtures utilized for intricate immunological analyses to detect and characterize antigen-antibody interactions. For instance, in May 2023, Creative Diagnostics, a US-based biotechnology company, launched a new single radial immunodiffusion testing service tailored for the biological industry, streamlining the process for researchers to accurately assess the concentration of antigens within samples. Leveraging the well-established agar gel precipitation technique, our service employs antibodies with defined specificity uniformly distributed within the agar gel. Samples containing the antigen of interest are strategically placed in wells within the gel, prompting the radial diffusion of the antigen. This diffusion results in the formation of a distinct precipitate ring, indicating the equilibrium point between antibodies and antigens. By precisely measuring the diameter of this ring and referencing it against a standard curve, our service accurately determines the concentration of the antigen, providing researchers with invaluable quantitative data.What Are Latest Mergers And Acquisitions In The Virology Testing Market?
In April 2025, Source BioScience UK Ltd, a UK-based healthcare technology company, acquired Cambridge Clinical Laboratories for an undisclosed amount. With this acquisition, Source BioScience aims to strengthen its clinical diagnostics portfolio by providing end-to-end preclinical and clinical testing services. Cambridge Clinical Laboratories is a UK-based healthcare technology company that specializes in personalized healthcare diagnostic services spanning oncology, virology, men’s health, gastroenterology, fertility, and validation studies for clinical research.Regional Outlook
North America was the largest region in the virology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Virology Testing Market?
The virology testing market consists of revenues earned by entities by providing services such as comprehensive viral screening, virucidal disinfectant efficacy testing, virus research, and testing for infectious disease agents. The market value includes the value of related goods sold by the service provider or included within the service offering. The virology testing market also includes sales of virology test kits, polymerase chain reaction (PCR) instruments, and enzyme-linked immunosorbent assay (ELISA) kits, which are used in providing virology testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Virology Testing Market Report 2026?
The virology testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the virology testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Virology Testing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $6.41 billion |
| Revenue Forecast In 2035 | $9.86 billion |
| Growth Rate | CAGR of 10.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Diagnostic Technique, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc., Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Vircell SL |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Virology Testing market was valued at $5.8 billion in 2025, increased to $6.41 billion in 2026, and is projected to reach $9.86 billion by 2030.
request a sample hereThe global Virology Testing market is expected to grow at a CAGR of 11.4% from 2026 to 2035 to reach $9.86 billion by 2035.
request a sample hereSome Key Players in the Virology Testing market Include, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc., Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Vircell SL .
request a sample hereMajor trend in this market includes: Advancements In Technology Drive Virology Testing Market Growth. For further insights on this market.
request a sample hereNorth America was the largest region in the virology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here